PTC Therapeutics (PTCT) Reports Q1 Loss Per Share of $1.15

PTC Therapeutics (NASDAQ: PTCT) reported Q1 EPS of ($1.15), may not compare to the analyst estimate of ($1.20). Revenue for the quarter came in at $7.48 million versus the consensus estimate of $2.97 million.

For earnings history and earnings-related data on PTC Therapeutics (PTCT) click here.

You May Also Be Interested In

• Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
• Integer Holdings Corp (ITGR) Tops Q1 EPS by 2c ; Offers Guidance
• Airbus revenue rises, delivers 142 commercial aircraft in Q1